Moxalactam pharmacokinetics during hemodialysis.
To establish dosage recommendations, moxalactam elimination kinetics were studied in six anephric patients during hemodialysis and in four anephric patients during the interdialytic period. After a single 1-g intravenous bolus injection, moxalactam elimination half-life was 18.0 plus or minus 0.6 h...
Gespeichert in:
| Veröffentlicht in: | Antimicrob Agents Chemother |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Microbiology (ASM)
1981
|
| Schlagworte: | |
| Online-Zugang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC181480/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6454386/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.19.4.575 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|